Carol A. Schafer's Insider Trades & SAST Disclosures
Carol A. Schafer's most recent trade in Insmed Inc was a trade of 5,058 Common Stock done . Disclosure was reported to the exchange on May 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Carol A. Schafer.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Insmed Inc | Carol A. Schafer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 5,058 | 63,317 (0%) | 0% | - | Common Stock | |
| Repare Therapeutics Inc | Carol A. Schafer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 27,200 | 27,200 | - | - | Stock Option (right to buy) | |
| Immunome Inc | Carol A. Schafer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 11,333 | 11,333 | - | - | Stock option (right to buy) | |
| Kura Oncology Inc | Carol A. Schafer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 26,000 | 26,000 | - | - | Option to purchase common stock | |
| Insmed Inc | Carol A. Schafer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 13,162 | 58,259 (0%) | 0% | - | Common Stock | |
| Immunome Inc | A. Schafer Carol | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 32,934 | 32,934 | - | - | Stock option (right to buy) | |
| Repare Therapeutics Inc | Carol A. Schafer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 27,200 | 27,200 | - | - | Stock Option (right to buy) | |
| Kura Oncology Inc | Carol A. Schafer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 26,000 | 26,000 | - | - | Option to purchase common stock | |
| Insmed Inc | Carol A. Schafer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 13,192 | 45,097 (0%) | 0% | - | Common Stock | |
| Kura Oncology Inc | Carol A. Schafer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 23,000 | 23,000 | - | - | Option to purchase common stock | |
| Repare Therapeutics Inc | Carol A. Schafer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 49,000 | 49,000 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Carol A. Schafer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 14,645 | 31,905 (0%) | 0% | - | Common Stock | |
| Kura Oncology Inc | Carol A. Schafer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 23,000 | 23,000 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Carol A. Schafer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 46,000 | 46,000 | - | - | Option to purchase common stock | |
| Repare Therapeutics Inc | Carol A. Schafer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 21,000 | 21,000 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Carol A. Schafer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 7,558 | 17,260 (0%) | 0% | - | Common Stock | |
| Repare Therapeutics Inc | Carol A. Schafer | Director | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 23 Jun 2020 | 8,000 | 8,000 | - | 20 | 160,000 | Common Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges